Who invested in Viking Therapeutics

2 rounds we have observed, with the one investor named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Healthcare

Funding summaryUpdated 26 Oct 2026

$635Mraised across 2 rounds since 2014, from 2 sources

$2.5MDebt$633MRound

Latest round: Round, $633MFeb 2024
Step-upi: 253×
Investors: 1

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

201420162018202020222024

$2.5MDebt$633MRound

First round: Debt, $2.5M
Biggest round: $633M
Between rounds: 9.7 years

The rounds

Feb 2024
Round$633M
No investor was named in the report.
Source recorded
May 2014
Debt$2.5M1 new
- Ligand Pharmaceuticals
From a historical funding record

Founders and team

From Viking Therapeutics's own website: 4 on the team.

Kenneth J. HermanSenior Vice President, Commercial, Marketing and Sales
Michael MorneauVice President, Finance and Administration
Tavette NeskorikVice President, Clinical Operations
Greg ZanteChief Financial Officer

Everyone who backed them

Ligand PharmaceuticalsGrowth equity1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Viking Therapeutics as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.